Location History:
- Kunitachi, JP (2009)
- Tokyo, JP (2011)
Company Filing History:
Years Active: 2009-2011
Title: Ayako Tosaka: Innovator in Pharmaceutical Chemistry
Introduction
Ayako Tosaka is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel therapeutic agents. With a total of 2 patents, her work focuses on addressing various health conditions through innovative chemical compounds.
Latest Patents
Ayako Tosaka's latest patents include the development of 2-oxochromene derivatives. This invention aims to provide a novel LXRβ agonist that is useful as a preventative and therapeutic agent for atherosclerosis, arteriosclerosis resulting from diabetes, dyslipidemia, hypercholesterolemia, lipid-related diseases, inflammatory diseases caused by inflammatory cytokines, skin diseases such as allergic skin diseases, diabetes, and Alzheimer's disease. The patent describes a 2-oxochromene derivative represented by a specific general formula or salt thereof, or their solvate. Another significant patent is a method for producing a cyclic diamine derivative, which serves as an ACAT inhibitor. This method outlines an industrially useful process for synthesizing the cyclic diamine derivative from a 2-hydroxyacetylaminopyridine compound through a series of defined steps.
Career Highlights
Ayako Tosaka is currently associated with Kowa Company Limited, where she continues to advance her research and development efforts. Her work has been instrumental in creating innovative solutions for complex health issues, showcasing her expertise in pharmaceutical chemistry.
Collaborations
Ayako collaborates with notable colleagues, including Kimiyuki Shibuya and Ayumu Okuda. These partnerships enhance her research capabilities and contribute to the success of her projects.
Conclusion
Ayako Tosaka is a remarkable inventor whose work in pharmaceutical chemistry has the potential to impact various health conditions significantly. Her innovative patents and collaborations reflect her dedication to advancing medical science.